433 related articles for article (PubMed ID: 29768256)
1. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of the Sonic Hedgehog (SHH) Gene Inhibits Proliferation of Hep3B and SMMC-7721 Hepatocellular Carcinoma Cells via the PI3K/Akt/PCK1 Signaling Pathway.
Chen Y; Zhu W
Med Sci Monit; 2019 Aug; 25():6023-6033. PubMed ID: 31406102
[TBL] [Abstract][Full Text] [Related]
3. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma.
Liu MX; Jin L; Sun SJ; Liu P; Feng X; Cheng ZL; Liu WR; Guan KL; Shi YH; Yuan HX; Xiong Y
Oncogene; 2018 Mar; 37(12):1637-1653. PubMed ID: 29335519
[TBL] [Abstract][Full Text] [Related]
5. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.
Shi H; Fang R; Li Y; Li L; Zhang W; Wang H; Chen F; Zhang S; Zhang X; Ye L
Cancer Lett; 2016 Nov; 382(2):147-156. PubMed ID: 27609066
[TBL] [Abstract][Full Text] [Related]
6. MiR-93-5P Represses the Gluconeogenesis of Hepatocellular Carcinoma while Boosting Its Glycolysis and Malignant Progression by Suppressing PCK1.
Zhou X; Huang L; Xing R; Yang F; Nie H
Crit Rev Eukaryot Gene Expr; 2022; 32(1):35-47. PubMed ID: 35377979
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma cell-derived extracellular vesicles encapsulated microRNA-584-5p facilitates angiogenesis through PCK1-mediated nuclear factor E2-related factor 2 signaling pathway.
Shao Z; Pan Q; Zhang Y
Int J Biochem Cell Biol; 2020 Aug; 125():105789. PubMed ID: 32522621
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
Liu R; Gou D; Xiang J; Pan X; Gao Q; Zhou P; Liu Y; Hu J; Wang K; Tang N
Oncogene; 2021 Dec; 40(50):6707-6719. PubMed ID: 34650217
[TBL] [Abstract][Full Text] [Related]
9. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation.
Xiang J; Chen C; Liu R; Gou D; Chang L; Deng H; Gao Q; Zhang W; Tuo L; Pan X; Liang L; Xia J; Huang L; Yao K; Wang B; Hu Z; Huang A; Wang K; Tang N
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690219
[TBL] [Abstract][Full Text] [Related]
10. The regulation of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase by autophagy in low-glycolytic hepatocellular carcinoma cells.
Jeon JY; Lee H; Park J; Lee M; Park SW; Kim JS; Lee M; Cho B; Kim K; Choi AM; Kim CK; Yun M
Biochem Biophys Res Commun; 2015 Jul; 463(3):440-6. PubMed ID: 26036577
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circC3P1 suppresses hepatocellular carcinoma growth and metastasis through miR-4641/PCK1 pathway.
Zhong L; Wang Y; Cheng Y; Wang W; Lu B; Zhu L; Ma Y
Biochem Biophys Res Commun; 2018 May; 499(4):1044-1049. PubMed ID: 29608893
[TBL] [Abstract][Full Text] [Related]
12. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
13. hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner.
Hao W; Chen Z; Tang J; Yang R; Gao WQ; Xu H
J Transl Med; 2023 Nov; 21(1):861. PubMed ID: 38017546
[TBL] [Abstract][Full Text] [Related]
14. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.
Xu D; Wang Z; Xia Y; Shao F; Xia W; Wei Y; Li X; Qian X; Lee JH; Du L; Zheng Y; Lv G; Leu JS; Wang H; Xing D; Liang T; Hung MC; Lu Z
Nature; 2020 Apr; 580(7804):530-535. PubMed ID: 32322062
[TBL] [Abstract][Full Text] [Related]
15. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation.
Bian XL; Chen HZ; Yang PB; Li YP; Zhang FN; Zhang JY; Wang WJ; Zhao WX; Zhang S; Chen QT; Zheng Y; Sun XY; Wang XM; Chien KY; Wu Q
Nat Commun; 2017 Feb; 8():14420. PubMed ID: 28240261
[TBL] [Abstract][Full Text] [Related]
16. Rev-erbα activation down-regulates hepatic Pck1 enzyme to lower plasma glucose in mice.
Yuan X; Dong D; Li Z; Wu B
Pharmacol Res; 2019 Mar; 141():310-318. PubMed ID: 30639375
[TBL] [Abstract][Full Text] [Related]
17. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
18.
Zheng J; Luo J; Zeng H; Guo L; Shao G
Biomed Pharmacother; 2019 Nov; 119():109402. PubMed ID: 31514072
[TBL] [Abstract][Full Text] [Related]
19. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
[TBL] [Abstract][Full Text] [Related]
20. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]